ARCHIVES

Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Mantel Film Getting Rave Reviews, Not Enough Air Time

July 18, 1986

NCI Offers Model Informed Consent Documents

November 6, 1998

ACS Approves New Workplaces Intervention Cancer Control Program

April 17, 1992

NCI Staff Phone Numbers Listed

September 14, 1979

Low Percentage Of Trials Published In Medical Journals

October 31, 2008

Nixon National Cancer Conference Kicks Off

December 8, 2021